Ligand validation:6W5L

T0D: (2~{S})-~{N}-[(1~{R})-1-[bis($l^{1}-oxidanyl)-methoxy-$l^{5}-sulfanyl]-1-oxidanyl-3-[(3~{R})-2-oxidanylidenepyrrolidin-3-yl]propan-2-yl]-2-[[[2-(3-chlorophenyl)-2-methyl-propoxy]-oxidanylidene-methyl]amino]-4-methyl-pentanamide

T0D is a Ligand Of Interest in 6W5L designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
6W5L_T0D_D_201	47%	10%	0.137	0.905	2.84	1.49	12	7	2	0	83%	0.825
6W5L_T0D_A_201	43%	10%	0.147	0.9	2.77	1.65	12	8	0	0	83%	0.825
6W5L_T0D_B_201	29%	9%	0.202	0.89	2.75	1.7	14	9	0	0	83%	0.825
6W5L_T0D_C_201	26%	10%	0.162	0.836	2.78	1.58	13	9	0	0	83%	0.825

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.